The National Health Commission said in a notice released on Tuesday that it has recently learned that some medical ...

Alzheimer's disease, which is a neurodegenerative disease that affects ... The fastest growth in older populations is ...

Education -- a proxy for cognitive reserve -- often correlates with better cognition, greater gray matter volume, improved ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

The 43,000 sq m facility – roughly the size of six football fields – features spaces that replicate familiar settings like a ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

The facility gives residents more choice and autonomy in daily living. Read more at straitstimes.com. Read more at ...

Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.

Scientists have uncovered a surprising sugar-related mechanism inside brain cells that could transform how we fight Alzheimer ...

This facility is China’s first Alzheimer’s disease care village, built by Singapore-based healthcare and real estate company Perennial Holdings and opened progressively from March 2024. The ...